| Literature DB >> 34350498 |
Fatemeh Yarmohammadi1,2, Hedyieh Karbasforooshan3, A Wallace Hayes4,5, Gholamreza Karimi6,7.
Abstract
Doxorubicin (DOX) is a potent chemotherapeutic agent; however, the accompanying cardiotoxicity is a significant complication of the usefulness of treatment with DOX. Multiple mechanisms have been suggested for this often fatal side effect, one of which is inflammation. Several pathways with different targets have been reported to result in DOX-induced heart inflammation. Some natural occurring compounds (NCs) have been reported to interact with the DOX-induced cardiotoxicity through targeting one or more of several pathways, including the Nrf2/NF-kB, TLR-4/NF-kB, MAPK/NF-kB, and NLRP3 inflammasome pathways. This article reviews several of these pathways and the potential protective effect of some NCs against the cardiac inflammation induced by DOX.Entities:
Keywords: Cardiac inflammation; NF-κB; NLRP3 inflammasome; Nrf2
Mesh：
Substances：
Year: 2021 PMID： 34350498 DOI： 10.1007/s00210-021-02132-z
Source DB: PubMed Journal: Naunyn Schmiedebergs Arch Pharmacol ISSN： 0028-1298 Impact factor: 3.000